Key result
Dysregulated endothelial cell-cardiomyocyte paracrine cross-talk drives pathophysiology across various cardiovascular diseases.
Why the study?
Understanding endothelial cell and cardiomyocyte paracrine cross-talk is critical for understanding tissue homeostasis, regeneration, and disease pathogenesis, and identifying novel diagnostic and therapeutic targets.
Understanding bidirectional paracrine signaling between endothelial cells and cardiomyocytes is critical for identifying novel diagnostic and therapeutic targets in cardiovascular disease.
To maintain homeostasis in the heart, endothelial cells and cardiomyocytes engage in dynamic cross-talk through paracrine signals that regulate both cardiac development and function. Here, we review the paracrine signals that endothelial cells release to regulate cardiomyocyte growth, hypertrophy and contractility, and the factors that cardiomyocytes release to influence angiogenesis and vascular tone. Dysregulated communication between these cell types can drive pathophysiology of disease, as seen in ischemia-reperfusion injury, diabetes, maladaptive hypertrophy, and chemotherapy-induced cardiotoxicity. Investingating the role of cross-talk is critical in developing an understanding of tissue homeostasis, regeneration, and disease pathogenesis, with the potential to identify novel targets for diagnostic and therapeutic purposes.
No takes yet. Share an insight, caveat, or question.
Adao et al. (2024) conducted a review in Cardiovascular homeostasis and disease. Endothelial cell-cardiomyocyte cross-talk via bidirectional paracrine signaling regulates cardiac homeostasis, and its dysregulation drives pathophysiology in various cardiovascular diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: